Concepedia

Yong Luo

YL

19

Publications

1.2K

Citations

16

H-Index

2006

Active since

Affiliations

Beijing Anzhen Hospital(Current)

Capital Medical University

Peking University

The University of Texas MD Anderson Cancer Center

Beijing Jishuitan Hospital

Yong Luo is an author at Beijing Anzhen Hospital specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2006–2019

19

Publications

19

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Likun Li, Styliani Karanika, Guang Yang et al. · Science Signaling · 2017 · 293 citations · Full text

Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1α

Yongguang Jiang, Yong Luo, Dalin He et al. · International Journal of Urology · 2007 · 218 citations

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer

Rong Xiang, Daiqing Liao, Tsu‐Yao Cheng et al. · British Journal of Cancer · 2011 · 173 citations · Full text

Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells

Ling Lan, Yong Luo, Dai Cui et al. · International Journal of Oncology · 2013 · 76 citations · Full text

, , +20

PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer

Bo Liu, Likun Li, Guang Yang et al. · Clinical Cancer Research · 2019 · 72 citations · Full text

Rows per page

1–5 of 19